Guardian Pharmacy Services (GRDN) Depreciation & Amortization (CF) (2023 - 2026)

Guardian Pharmacy Services' Depreciation & Amortization (CF) history runs 4 years deep, the most recent figure standing at $6.0 million for Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) rose 13.46% year-over-year to $6.0 million; the TTM figure through Mar 2026 stood at $23.0 million (up 13.58% YoY), while the FY2025 annual figure was $22.3 million, up 12.96% from the prior year.
• Depreciation & Amortization (CF) came in at $6.0 million for Q1 2026 at Guardian Pharmacy Services, up from $5.7 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $6.0 million in Q1 2026 to a low of $4.7 million in Q4 2023.
• A 4-year average of $5.3 million and a median of $5.2 million in 2024 frame the typical range for Depreciation & Amortization (CF).
• Across the five-year window, Depreciation & Amortization (CF) advanced 9.31% in 2024 and rose 16.9% in 2025, its largest moves.
• Guardian Pharmacy Services' Depreciation & Amortization (CF) stood at $4.7 million in 2023, then rose by 9.31% to $5.2 million in 2024, then advanced by 11.41% to $5.7 million in 2025, then advanced by 4.09% to $6.0 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $6.0 million, $5.7 million, and $5.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison